News and Comments

IDERA (IDRA): GOOD NEWS OFFSET SOMEWHAT BY SKEPTICISM NOT PESSIMISM

  Monday, March 04, 2013

Forgetting about Idera Pharmaceuticals (IDRA) seems to make its value sink, but failed to make it disappear. With a stock that sells at less than a three quarter of a dollar and a market of $20 million, lower than a new comer biotech having drugs still in preclinical lab testing, the firm was capable of drawing investors’ attention, riding new data about an attractive possibility of beating all existing approaches to treating psoriasis. The surprising data, which bring hopes in treating other autoimmune diseases, in addition to psoriasis were presented by James G. Krueger, M.D., PhD, of The Rockefeller University, at the Late-Breaking Research Symposium on March 2nd, 2013, during the American Academy of Dermatology Annual Meeting. More...


Recent Postings


Archive


Tags

Multiple Myeloma Roche (ROCHE) Dynavax (DVAX) GUARDIAN HEALTH Anacor (ANAC) INNOVIVA (INVA) ARCA (ABIO) Sequenom (SQNM) PTC Therapeutics (PTCT) Elan (ELN) ARGOS (ARGS) Mirati Therapeutics (MRTX) Array Pharmaceuticals (ARRY) Onyx (ONXX) Ziofpharm (ZIOP) Intercept (ICPT) Pluristem (PSTI) ACADIA (ACAD) Jazz Pharmaceuticals (JAZZ) Benlysta (belimumab) Incyte (INCY) Ariad (ARIA) Agenus (AGEN Theravance (THRX) Exelixis (EXEL) Valeant Pharmaceuticals International (VRX) Spike Therapeutics (ONCE) NEKTAR (NKTR)) Zerenex Vertex (VRTX) Roche (RHHBY) ZALTRAP™ Theravance Bio Pharma (TBPH) Vitae Pharmaceuticals (VTAE) IDERA (IDRA) Rapamune MODERNA galapagos (GLPG) VANDA (VNDA) Gilead (GILD) HALOZYME (HALO) Auspex (ASPX) SUNESIS PHARMACEUTICALS (SNSS) Abbott Laboratories (ABT) Herceptin OSI (OSIP) Endometrial Cancer ADVENTRIX (ANX) JUNO (JUNO) Idenix (IDIX) Cytokinetics (CYTK) Tysabri Revlimid (lenolidamide) Intermune (ITMN) KITE (KITE) AGOS (ARGS) Illumina (ILMN) Biocryst (BCRX) NOVOCURE (NVCR) ISIS (ISIS) Genentech AstraZeneca (AZN) Alder Biopharmaceuticals (ALDR) ImmunoGen (IMGN) Xoma (XOMA) Galena (GALE) Sanofi (SNY) BIOMARIN (BMRN) Micromet (MITI) Prolor Biotech (PBTH) Aimmune Therapeutics (AIMT) SYNTA (SNTA) Editas (EDIT) C4 Therapeutics Biogen Idec (BIIB) Sangamo (SGMO) Human Longevity (HLI) Sanofi (SNA) Inovio (INO) Anadys (ANDS) Amgen (AMGN) REGULUS (RGLS) Ionis (IONS) Agenus (AGEN) RenenxBio (RGNX) Sanofi-Aventis (SAN) Bristol-Myers Squibb (BMY) NANTKWEST (NK) Global Cell Therapeutics (GBT) ABBVIE (ABBV) Dendreon (DNDN) Telaprevir GlaxoSmithKline (GSK) Seattle Genetics (SGEN) Trastuzumab-DM1 Prosensa (RNA) Merck (MRK) SERES THERAPEUTICS (MCRB) Ridaforolimus Regeneron (REGN) AERIE PHARMACEUTICALS Intrexon (XON) KERYX (KERX) CompuGen (CGEN) Human Genome Sciences (HGSI) Velcade (bortezomib) Alnylam (ALNY) TOKAI (TKAOI) Sarepta (SRPT)